GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Beginning Cash Position

Exicure (STU:2H0A) Beginning Cash Position : €1.95 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Exicure Beginning Cash Position?

Exicure's Beginning Cash Position for the quarter that ended in Dec. 2023 was €1.95 Mil.

Exicure's quarterly Beginning Cash Position declined from Jun. 2023 (€10.30 Mil) to Sep. 2023 (€3.31 Mil) and declined from Sep. 2023 (€3.31 Mil) to Dec. 2023 (€1.95 Mil).

Exicure's annual Beginning Cash Position increased from Dec. 2021 (€30.50 Mil) to Dec. 2022 (€41.39 Mil) but then declined from Dec. 2022 (€41.39 Mil) to Dec. 2023 (€8.97 Mil).


Exicure Beginning Cash Position Historical Data

The historical data trend for Exicure's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exicure Beginning Cash Position Chart

Exicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 23.64 39.83 30.50 41.39 8.97

Exicure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.90 9.13 10.30 3.31 1.95

Exicure Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Exicure Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Exicure's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Exicure (STU:2H0A) Business Description

Traded in Other Exchanges
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Exicure (STU:2H0A) Headlines

No Headlines